|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000011111 |
|
Date of registration:
|
15/07/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Spinal blood flow and metabolism in neurological diseases
|
|
Scientific title:
|
Spinal blood flow and metabolism in neurological diseases - Spinal blood flow and metabolism in neurological diseases |
|
Date of first enrolment:
|
2013/07/16 |
|
Target sample size:
|
70 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013014 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Toru Yamashita |
|
Address:
|
2-5-1 Shikatacho, Okayama
Japan |
|
Telephone:
|
086-235-7365 |
|
Email:
|
toruyamashita@cc.okayama-u.ac.jp |
|
Affiliation:
|
Okayama University Hospital Neurology |
|
|
Name:
|
Koji Abe |
|
Address:
|
2-5-1 Shikatacho, Okayama
Japan |
|
Telephone:
|
81-86-235-7365 |
|
Email:
|
tooy@d1.dion.ne.jp |
|
Affiliation:
|
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Neurology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: None
Age minimum:
20years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
motor neuron disease including ALS, multiple sclerosis, stroke, Parkinson disease, spinocerebellar degeneration, multiple system atrophy
|
|
Intervention(s)
|
PET scan study with 11C-flumazenil
PET scan study with 18F- FDG
PET scan study with 15O-H2O
|
|
Primary Outcome(s)
|
|
Signal intensity of each PET image (11C- flumazenil,18F- FDG, 15O-H2O) (spinal cord C1-C6 level)
|
|
Source(s) of Monetary Support
|
|
Japan society for the promotion of science
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|